0001615774-15-000673.txt : 20150403 0001615774-15-000673.hdr.sgml : 20150403 20150403164329 ACCESSION NUMBER: 0001615774-15-000673 CONFORMED SUBMISSION TYPE: 3 PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20150403 FILED AS OF DATE: 20150403 DATE AS OF CHANGE: 20150403 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Enumeral Biomedical Holdings, Inc. CENTRAL INDEX KEY: 0001561551 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 990376434 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: ONE KENDALL SQUARE, STREET 2: BUILDING 400, 4TH FLOOR CITY: CAMBRIDGE STATE: MA ZIP: 02139 BUSINESS PHONE: (617) 674-1865 MAIL ADDRESS: STREET 1: ONE KENDALL SQUARE, STREET 2: BUILDING 400, 4TH FLOOR CITY: CAMBRIDGE STATE: MA ZIP: 02139 FORMER COMPANY: FORMER CONFORMED NAME: CERULEAN GROUP, INC. DATE OF NAME CHANGE: 20121102 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Nguyen Anhco T. CENTRAL INDEX KEY: 0001616743 FILING VALUES: FORM TYPE: 3 SEC ACT: 1934 Act SEC FILE NUMBER: 000-55415 FILM NUMBER: 15751674 MAIL ADDRESS: STREET 1: C/O ENUMERAL BIOMEDICAL HOLDINGS, INC., STREET 2: ONE KENDALL SQUARE, BUILDING 400, 4TH FL CITY: CAMBRIDGE STATE: MA ZIP: 02139 3 1 s100516_form3.xml 3 X0206 3 2015-04-03 0 0001561551 Enumeral Biomedical Holdings, Inc. ENUM 0001616743 Nguyen Anhco T. C/O ENUMERAL BIOMEDICAL HOLDINGS, INC., 200 CAMBRIDGE PARK DRIVE, SUITE 2000 CAMBRIDGE MA 02140 0 1 0 0 VP of Research and Development Common Stock 0 D Employee Stock Option (Right to Buy) 1.0000 2024-07-30 Common Stock 90000 D Employee Stock Option (Right to Buy) 1 2024-07-17 Common Stock 28655 D Employee Stock Option (Right to Buy) 0.245 2023-07-25 Common Stock 49595 D Employee Stock Option (Right to Buy) 0.245 2022-10-26 Common Stock 35819 D Employee Stock Option (Right to Buy) 0.245 2022-10-26 Common Stock 35819 D The option vests and becomes exercisable as follows: (a) 15,000 shares will vest in 48 equal monthly installments beginning on July 31, 2014, and (b) 75,000 shares will vest upon the achievement of certain performance criteria. The option vests and becomes exercisable in 48 equal monthly installments beginning on July 25, 2013. The option vests and becomes exercisable upon the achievement of certain performance criteria. The option vests and becomes exercisable as follows: (a) as to 23,878 shares, in 48 equal monthly installments beginning on November 26, 2012; and (b) as to 11,941 shares, upon the achievement of certain performance criteria. The option vests and becomes exercisable as follows: (a) 3,857 shares on October 26, 2012; (b) 5,511 shares on January 4, 2013; (c) as to 16,532 shares, in 36 equal monthly installments beginning on February 4, 2013; and (d) as to 9,919 shares, upon the achievement of certain performance criteria. Represents an option issued to the reporting person in exchange for an option previously issued by Enumeral Biomedical Corp. (the "Predecessor") pursuant to the terms of the merger of the Predecessor with a wholly-owned subsidiary of the Issuer. /s/ Anhco Nguyen 2015-04-03 EX-24.1 2 ex24-1.htm EX-24.1

Exhibit 24.1

POWER OF ATTORNEY

Know all by these presents, that the undersigned hereby constitutes and appoints each of Arthur Tinkelenberg and Kevin Sarney, or either of them signing individually, and with full power of substitution, the undersigned's true and lawful attorney-in-fact to:

(1)

prepare, execute in the undersigned’s name and on the undersigned’s behalf, and submit to the U.S. Securities and Exchange Commission (the “SEC”) a Form ID, including amendments thereto, and any other documents necessary or appropriate to obtain codes and passwords enabling the undersigned to make electronic filings with the SEC of reports required by Section 16(a) of the Securities Exchange Act of 1934, as amended (the "Exchange Act") or any rule or regulation of the SEC;

(2)

execute for and on behalf of the undersigned, in the undersigned's capacity as an officer and/or director of Enumeral Biomedical Holdings, Inc. (the “Company”), Forms 3, 4, and 5 (including amendments thereto and joint filing agreements in connection therewith) in accordance with Section 16(a) of the Exchange Act and the rules thereunder;

(3)

do and perform any and all acts for and on behalf of the undersigned which may be necessary or desirable to complete and execute any such Form 3, 4, or 5, (including amendments thereto and joint filing agreements in connection therewith) and file such forms with the SEC and any stock exchange, self-regulatory association or any similar authority; and

(4)

take any other action of any type whatsoever in connection with the foregoing which, in the opinion of such attorney-in-fact, may be of benefit to, in the best interest of, or legally required by, the undersigned, it being understood that the documents executed by such attorney-in-fact on behalf of the undersigned pursuant to this Power of Attorney shall be in such form and shall contain such terms and conditions as such attorney-in-fact may approve in such attorney-in-fact's discretion.

The undersigned hereby grants to each such attorney-in-fact full power and authority to do and perform any and every act and thing whatsoever requisite, necessary, or proper to be done in the exercise of any of the rights and powers herein granted, as fully to all intents and purposes as the undersigned might or could do if personally present, with full power of substitution or revocation, hereby ratifying and confirming all that such attorney-in-fact, or such attorney-in-fact's substitute or substitutes, shall lawfully do or cause to be done by virtue of this power of attorney and the rights and powers herein granted. The undersigned acknowledges that the foregoing attorneys-in-fact, and their substitutes, in serving in such capacity at the request of the undersigned, are not assuming (nor is the Company assuming) any of the undersigned's responsibilities to comply with Section 16 of the Exchange Act.

This Power of Attorney shall remain in full force and effect until the undersigned is no longer required to file Forms 3, 4, and 5 with respect to the undersigned's holdings of and transactions in securities issued by the Company, unless earlier revoked by the undersigned in a signed writing delivered to the foregoing attorneys-in-fact.

IN WITNESS WHEREOF, the undersigned has caused this Power of Attorney to be executed as of this 30th day of September , 2014.

	/s/ Anhco T. Nguyen
	Signature

	Anhco T. Nguyen
	Print Name